Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment o… Read more
Botanix Pharmaceuticals Limited (BXPHF) - Total Liabilities
Latest total liabilities as of June 2025: $47.80 Million USD
Based on the latest financial reports, Botanix Pharmaceuticals Limited (BXPHF) has total liabilities worth $47.80 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Botanix Pharmaceuticals Limited - Total Liabilities Trend (1989–2025)
This chart illustrates how Botanix Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Botanix Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of Botanix Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tonnellerie Francois Freres SA
PA:TFF
|
France | €464.31 Million |
|
Shenzhen Breo Technology Co. Ltd. A
SHG:688793
|
China | CN¥397.87 Million |
|
Parker Drilling Company
PINK:PKDC
|
USA | $328.95 Million |
|
Advantage Solutions Inc
NASDAQ:ADV
|
USA | $2.29 Billion |
|
Eclat Forever Machinery Co., Ltd.
TWO:3485
|
Taiwan | NT$196.49 Million |
|
JEIO CO LTD (PROPOSED)
KQ:418550
|
Korea | ₩40.00 Billion |
|
Hercules Metals Corp.
V:BIG
|
Canada | CA$1.71 Million |
|
Advanced Information Technology Public Company Limited
BK:AIT
|
Thailand | ฿2.60 Billion |
Liability Composition Analysis (1989–2025)
This chart breaks down Botanix Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.59 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Botanix Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Botanix Pharmaceuticals Limited (1989–2025)
The table below shows the annual total liabilities of Botanix Pharmaceuticals Limited from 1989 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $47.80 Million | +1180.69% |
| 2024-06-30 | $3.73 Million | +97.99% |
| 2023-06-30 | $1.88 Million | -67.97% |
| 2022-06-30 | $5.89 Million | +411.76% |
| 2021-06-30 | $1.15 Million | -31.31% |
| 2020-06-30 | $1.67 Million | -63.48% |
| 2019-06-30 | $4.58 Million | +221.60% |
| 2018-06-30 | $1.43 Million | +202.93% |
| 2017-06-30 | $470.60K | -8.77% |
| 2016-06-30 | $515.83K | +463.23% |
| 2015-06-30 | $91.58K | -70.44% |
| 2014-06-30 | $309.85K | -87.65% |
| 2013-06-30 | $2.51 Million | +6.71% |
| 2012-06-30 | $2.35 Million | +3.42% |
| 2011-06-30 | $2.27 Million | +22.57% |
| 2010-06-30 | $1.86 Million | +62.88% |
| 2009-06-30 | $1.14 Million | +5.28% |
| 2008-06-30 | $1.08 Million | +79.27% |
| 2007-06-30 | $603.47K | +112.57% |
| 2006-06-30 | $283.89K | +27.17% |
| 2005-06-30 | $223.25K | +22.92% |
| 2004-06-30 | $181.62K | -37.22% |
| 2003-06-30 | $289.29K | -36.82% |
| 2002-06-30 | $457.88K | +170.40% |
| 2001-06-30 | $169.34K | +43.51% |
| 2000-06-30 | $118.00K | -98.54% |
| 1999-06-30 | $8.06 Million | -44.80% |
| 1998-06-30 | $14.61 Million | -19.80% |
| 1997-06-30 | $18.22 Million | -4.79% |
| 1996-06-30 | $19.13 Million | -35.62% |
| 1995-06-30 | $29.72 Million | +31.96% |
| 1994-06-30 | $22.52 Million | +14.41% |
| 1993-06-30 | $19.68 Million | +35.61% |
| 1992-06-30 | $14.52 Million | -0.16% |
| 1991-06-30 | $14.54 Million | +6.72% |
| 1990-06-30 | $13.62 Million | +15.26% |
| 1989-06-30 | $11.82 Million | -- |